Designing Longevity
Skip to main content
Moderate EvidencePeptide

BPC-157

Body Protection Compound

Cytoprotective Peptide

Last updated: December 2025
Share:

Evidence Level: Moderate Evidence

Some human data, strong animal studies, plausible mechanism

Regulatory Status: Not FDA approved. Sold as "research chemical" in gray market.

BPC-157 is a peptide (a short chain of amino acids) derived from a protein found in human gastric juice. It's been extensively studied in animals for its remarkable healing properties, gut protection, tendon repair, wound healing. Human data is limited, but it's become popular in biohacking circles for injury recovery and gut issues.

How It Works

BPC-157 appears to work through multiple mechanisms:

: Promotes new blood vessel formation, bringing more nutrients and oxygen to damaged tissue.

Growth factors: Upregulates receptors for growth hormone and other healing signals.

Nitric oxide modulation: Helps regulate inflammation and blood flow.

Gut protection: Protects the stomach lining and may help repair intestinal damage.

The research is compelling in animals, but we're still waiting for robust human trials. Most of what we "know" comes from rodent studies and anecdotal reports.

Evidence by Outcome

Each claim below is rated using a GRADE-aligned five-tier system. Same molecule, different outcomes, different evidence.

Want to see how this compares to every other peptide? Browse the full evidence matrix, where every graded claim is grouped by outcome and sorted by certainty.

Tissue repair / healingPreclinical certainty

Accelerates healing of tendon, ligament, muscle, and bone injuries.

Population: No adequately controlled human population has been studied. Evidence is from rodent and other animal injury models.

Why this rating

This is the claim BPC-157 is sold on, and the animal evidence behind it is genuinely extensive and consistent across many independent laboratories. It stays at because a 2025 systematic review of the whole literature through June 2024 found 36 studies, of which 35 were in animals and 1 was clinical. Consistent animal healing data has a poor record of predicting human musculoskeletal outcomes, and the review itself concluded the compound should not be recommended clinically until human trials exist.

Supporting studies

Reviewed September 2026· Designing Longevity EditorialHow we grade
Tissue repair / healingVery Low certainty

Reduces chronic knee pain after intra-articular injection.

Population: Adults with chronic knee pain, in a small retrospective case series

Why this rating

The only human efficacy data of any kind is a retrospective review of 16 patients reporting pain relief in 14 of them. There was no control group, no randomization, and no blinding, in a condition where placebo response to an injection is large and well documented. This is a reason to run a trial, not evidence that the treatment works.

GRADE downgrade factors applied

  • Risk of bias: Methodological flaws in the studies (e.g. lack of blinding, allocation concealment, high attrition).
  • Imprecision: Wide confidence intervals or small sample size, the estimate could be substantially different.
  • Publication bias: Suspicion that negative or null results were not published, inflating apparent effect.

Supporting studies

Reviewed September 2026· Designing Longevity EditorialHow we grade
Gut healthPreclinical certainty

Heals the gut lining and protects against NSAID-induced damage.

Population: No human population has been studied. Evidence is from rodent models of ulcer, colitis, and NSAID injury.

Why this rating

BPC-157 was originally isolated from gastric juice and the rodent gastrointestinal data is the oldest and most replicated part of its literature. No controlled human trial has tested it for any gut condition, so the entire case for the use people most often buy it for rests on animal work.

Supporting studies

Reviewed September 2026· Designing Longevity EditorialHow we grade

Potential Benefits

  • Animal studies show accelerated tendon and ligament healing
  • May help repair gut lining (IBD, leaky gut, ulcers)
  • Neuroprotective effects seen in animal models
  • Appears to protect against NSAID-induced gut damage
  • Generally well-tolerated in anecdotal reports
  • Can be taken orally or injected (oral for gut, injection for systemic)

Risks & Considerations

  • No FDA approval, buying from gray market sources
  • Limited human clinical trial data
  • Quality control varies wildly between vendors
  • Potential to promote could theoretically be problematic in cancer
  • Long-term effects unknown
  • Legal gray area (sold "for research only")
  • Interactions with other medications unknown

Dosing Information

There is no official dosing since BPC-157 is not approved for human use. The following reflects common practices in the biohacking community.

  • Common dose range: 250-500mcg per day
  • Oral route (capsules): Better for gut-specific issues
  • Subcutaneous injection: For systemic or localized effects
  • Typical cycle: 4-8 weeks
  • "Stable" version (arginine salt) preferred for oral use
  • Inject near injury site for localized issues

Need to mix this from a vial?

Use our reconstitution calculator to get the exact insulin syringe units to draw.

Practical Tips

  • 1If using for gut issues, oral route makes more sense
  • 2For tendon/injury repair, subcutaneous injection near the site is common
  • 3Source matters enormously, buy from reputable peptide vendors with COAs
  • 4Store peptide in refrigerator
  • 5Start with lower dose to assess tolerance
  • 6Not a replacement for proper medical care for serious injuries

Key Research

Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review

HSS Journal, 2025

Reviewed the entire English-language BPC-157 literature from database inception to June 2024 and found 36 studies, of which 35 were and 1 was clinical. Concluded that BPC-157 should not be recommended for clinical use in musculoskeletal medicine until well-designed human trials are published.

View Study

Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing

Current Reviews in Musculoskeletal Medicine, 2025

Maps the mechanisms (VEGFR2 and nitric oxide signalling via the Akt-eNOS axis, ERK1/2, , fibroblast activity) demonstrated across animal models, alongside the safety and regulatory concerns.

View Study

Intra-Articular Injection of BPC-157 for Multiple Types of Knee Pain

Alternative Therapies in Health and Medicine, 2021

A retrospective review of 16 patients given an intra-articular knee injection reported that 14 (87.5%) had meaningful pain relief at 6 to 12 months. There was no control group and no randomization.

View Study

Considering BPC-157 for recovery?

Research peptides require careful sourcing. Here are trusted options.

Compare with TB-500Peptide Safety Guide

Always consult a healthcare provider before starting any treatment.

Frequently Asked Questions

Is BPC-157 legal?

BPC-157 exists in a legal gray area. It's not FDA-approved for human use and is typically sold as a "research chemical." Possession for personal use is generally not prosecuted, but selling it for human consumption is technically illegal. It's not a controlled substance like steroids, but it's not a regulated dietary supplement either. The legality may vary by country.

How long does BPC-157 take to work?

Anecdotal reports suggest noticeable effects within 1-2 weeks for many users, though this varies by the type and severity of injury. For gut issues, some people report improvement within days. For tendon or ligament injuries, it may take 2-4 weeks to notice meaningful improvement. Most protocols run 4-8 weeks total.

Should I inject BPC-157 or take it orally?

It depends on your goal. For gut-related issues (IBS, leaky gut, ulcers, NSAID damage), oral capsules are often preferred since the peptide reaches the GI tract directly. For systemic effects or localized injuries (tendons, muscles, joints), subcutaneous injection, ideally near the injury site, is generally considered more effective, though the evidence is largely anecdotal.

What are the side effects of BPC-157?

BPC-157 is generally reported as well-tolerated with minimal side effects in anecdotal reports. The most common issues are injection site discomfort and occasional nausea with oral dosing. However, long-term safety is unknown, and there's a theoretical concern about promoting blood vessel growth in unwanted areas (like tumors). No serious adverse events have been reported in the limited research.

Can I stack BPC-157 with TB-500?

Yes, combining BPC-157 and TB-500 is a common practice in biohacking communities, often called the "healing stack." The theory is they work through complementary mechanisms, BPC-157 acts more locally while TB-500 has systemic effects. There's no clinical evidence for the combination's safety or efficacy, but anecdotal reports are generally positive.

Where should I inject BPC-157?

For localized effects, inject subcutaneously as close to the injured area as possible. For systemic effects or when the injury site isn't accessible, inject in the abdominal fat or thigh. Rotate injection sites to avoid irritation. Always use sterile technique with alcohol swabs and fresh needles.

How do I store BPC-157?

(powder) BPC-157 can be stored at room temperature, but refrigeration extends shelf life. Once with , it must be refrigerated and typically used within 2-4 weeks. Never freeze reconstituted peptides, and protect from light exposure.

Is BPC-157 the same as the BPC-157 in gastric juice?

BPC-157 is derived from a protein called BPC (Body Protection Compound) found naturally in human gastric juice, but it's not identical. BPC-157 is a synthetic 15-amino-acid fragment of the larger natural protein, specifically selected for its healing properties. It's more stable than the natural compound.

New to Peptides?

Learn the basics of peptide therapy, how to inject safely, and what to look for in quality sources.

Compare BPC-157

Disclaimer: This information is for educational purposes only and is not medical advice. Many peptides discussed are not FDA-approved for human use. Always consult with a qualified healthcare provider before starting any treatment. Evidence levels and regulatory status can change, this content was last updated December 2025.

Found this helpful? Share it or save it for later.

Share: